SECsense Logo

Aquestive Therapeutics 8-K Filing: Key Insights from February 12, 2025

$AQST
Form 8-K
Filed on: 2025-02-12
Source
Aquestive Therapeutics 8-K Filing: Key Insights from February 12, 2025

Based on the provided XML section of the financial report, here are the key insights extracted:

  1. Entity Information:
  • Company Name: Aquestive Therapeutics, Inc.
  • CIK: 0001398733
  • State of Incorporation: Delaware (DE)
  • SEC Central Index Key (CIK): 0001398733
  • SEC File Number: 001-38599
  • Employer Identification Number (EIN): 82-3827296
  • Address: 30 Technology Drive, Warren, NJ 07059
  • Contact Number: 908-941-1900
  1. Filing Type:
  • Form Type: 8-K (This form is used to report major events that shareholders should know about.)
  1. Filing Date:
  • Date of Filing: February 12, 2025
  1. Stock Information:
  • Common Stock: Par value of $0.001 per share
  • Stock Ticker: AQST
  • Exchange: NASDAQ
  1. Period of Reporting:
  • Start Date: February 12, 2025
  • End Date: February 12, 2025 (indicating that the filing is likely regarding a specific event on this date)

Summary:

Aquestive Therapeutics, Inc. has filed an 8-K report on February 12, 2025, related to a significant event. The company is publicly traded on NASDAQ under the ticker symbol AQST, with a par value of $0.001 for its common stock. The filing reflects a snapshot of the company's information and operations pertinent to that date.